engcon AB Cl B (ENGCON-B)
Nasdaq Stockholm · Sweden · prices in SEK · close of 27 Oct 2026
Key indicators
| Last close | SEK 74.50 |
|---|---|
| 52-week range | 55.00 – 90.70 |
| Return, 1 month / 3 months | +4.8% / +13.4% |
| Return, 1 year / 3 years | −2.3% / +13.5% |
| Trend | Uptrend |
| RSI (14) | 59 |
| Volatility (1 year) | 39.1% |
| Worst drawdown (1 year) | -36.6% |
| Average daily value traded | 9.37M SEK |
| Dividend yield | 1.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
engcon AB makes hydraulic attachments that let excavators work more flexibly. Its main products are tiltrotators, which allow a bucket to rotate and tilt, together with quick couplers, buckets, grapples and control systems. The company is based in Sweden and supplies contractors, machine operators and equipment dealers in construction, earthmoving and utility work across many countries. It also provides installation and service support for its attachment systems.
On this site engcon AB Cl B appears as a stock on the Nasdaq Stockholm (Sweden), code ENGCON-B, with prices in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
engcon AB Cl B (ENGCON-B) trades on the Nasdaq Stockholm in Sweden. It last closed at SEK 74.50 on 27 October 2026.
Its price-based Market X-Ray is 66 out of 100 (a fair price profile), ranking 253 of 912 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 2.3% and over the last three months it rose 13.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Nasdaq Stockholm
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 72 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 9.5% | ||
| From 52-week high | -16.6% | ||
| Momentum | 74 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 13.4% | ||
| 6-month return | 24.1% | ||
| 12-month return, skipping the last month | -6.8% | ||
| Stability (higher is calmer) | 61 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 39.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -36.6% | ||
| Liquidity | 78 · Strong | Trades actively. | |
| Average daily value traded | 9.37M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | 23 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.3% | ||
| Years with dividends | 4 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +1.2% |
|---|---|
| 1 month | +4.8% |
| 3 months | +13.4% |
| 6 months | +24.1% |
| 1 year | −2.3% |
| 3 years | +13.5% |
| 5 years | – |
Signals
| 50-day / 200-day average | 69.95 / 68.06 |
|---|---|
| Golden / death cross (60 days) | Golden, 7 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.20 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 2 Oct 2026 | SEK 0.5000 |
| 6 May 2026 | SEK 0.5000 |
| 10 Oct 2025 | SEK 0.5000 |
| 16 May 2025 | SEK 0.5000 |
| 30 Sep 2024 | SEK 0.4700 |
| 3 May 2024 | SEK 0.4700 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Nasdaq Stockholm; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.